Drug pricing

The rising price of antipsychotics and what it means

Data analysis has revealed that the drug tariff for some mental health medicines has increased by more than 1,200% as demand has risen.…

UK government rules out purchase of Evusheld over lack of data 

A spokesperson from the UK government has said it will "continue to explore the market for promising treatments that could prevent infection".…

Competition watchdog issues £100m in fines for liothyronine tablet price hikes

A series of price increases between 2009 and 2017 led to liothyronine tablets being placed on the NHS 'drop list' and some patients having their treatment stopped, the Competition and Markets Authority said.…

Revealed: the generic price hikes increasing the NHS drugs bill

Far from being a money saver, the generic medicines market has cost the NHS an additional £76m over the past two years.…

Generic drug price increases of up to 1,700% have cost the NHS £76m

An investigation by The Pharmaceutical Journal reveals that drug tariff prices for 33 generic “Category A” medicines were found to have more than doubled between July 2018 and October 2020.…

NHS England boss accuses Priadel manufacturer of using COVID-19 to ‘price-gouge’ British taxpayers

The chief executive of NHS England has accused the manufacturer of a first-line medication for bipolar disorder of “trying to jack the prices of a long-standing medicine”.…

Pharmacy negotiators consider move to quarterly margins survey

The Pharmaceutical Services Negotiating Committee is considering whether a quarterly margins survey would provide an “overall smoother delivery of margin” for community pharmacy.…

NHS England strikes deal with Orkambi manufacturer

Patients in England with cystic fibrosis will now have access to three new cystic fibrosis drugs on the NHS, following an agreement between the manufacturer and the government.…

No-deal Brexit likely to increase cost of new medicines, Scottish government says

The Scottish government has said it is “likely that the cost of new medicines in the UK will increase” under a no-deal Brexit.…

Competition and Markets Authority accepts £8m from drug firm accused of price fixing

The Competition and Markets Authority has accepted an offer of £8m to be paid to the NHS by a drug manufacturer as part of an agreement following allegations of anticompetitive behaviour and the supply of a prescription drug.…